Celanese Corporation (CE) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.017x

Based on the latest financial reports, Celanese Corporation (CE) has a cash flow conversion efficiency ratio of 0.017x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($76.00 Million) by net assets ($4.49 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See defensive interval ratio of Celanese Corporation to measure how many days the company can operate on defensive assets alone.

Celanese Corporation - Cash Flow Conversion Efficiency Trend (2001–2025)

This chart illustrates how Celanese Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Celanese Corporation Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Celanese Corporation ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Renk Group AG
XETRA:R3NK
0.058x
Corcept Therapeutics Incorporated
NASDAQ:CORT
-0.026x
Strathcona Resources Ltd.
TO:SCR
0.044x
APL Apollo Tubes Limited
NSE:APLAPOLLO
0.241x
Kite Realty Group Trust
NYSE:KRG
0.033x
BRF S.A
SA:BRFS3
0.142x
CNOOC Energy Technology & Services Ltd
SHG:600968
0.156x
China Coal Energy Company Limited
F:CVV
0.030x

Annual Cash Flow Conversion Efficiency for Celanese Corporation (2001–2025)

The table below shows the annual cash flow conversion efficiency of Celanese Corporation from 2001 to 2025. For the full company profile with market capitalisation and key ratios, see CE company net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $4.47 Billion $1.15 Billion 0.256x +48.80%
2024-12-31 $5.61 Billion $966.00 Million 0.172x -31.51%
2023-12-31 $7.55 Billion $1.90 Billion 0.251x -15.61%
2022-12-31 $6.11 Billion $1.82 Billion 0.298x -23.06%
2021-12-31 $4.54 Billion $1.76 Billion 0.387x +77.46%
2020-12-31 $3.90 Billion $850.00 Million 0.218x -56.50%
2019-12-31 $2.90 Billion $1.45 Billion 0.502x +8.81%
2018-12-31 $3.38 Billion $1.56 Billion 0.461x +89.43%
2017-12-31 $3.30 Billion $803.00 Million 0.243x -17.66%
2016-12-31 $3.02 Billion $893.00 Million 0.296x -2.99%
2015-12-31 $2.83 Billion $862.00 Million 0.305x -2.51%
2014-12-31 $3.08 Billion $962.00 Million 0.313x +10.70%
2013-12-31 $2.70 Billion $762.00 Million 0.282x -32.35%
2012-12-31 $1.73 Billion $722.00 Million 0.417x -12.28%
2011-12-31 $1.34 Billion $638.00 Million 0.476x -2.74%
2010-12-31 $924.00 Million $452.00 Million 0.489x -52.07%
2009-12-31 $584.00 Million $596.00 Million 1.021x -67.96%
2008-12-31 $184.00 Million $586.00 Million 3.185x +500.38%
2007-12-31 $1.07 Billion $566.00 Million 0.530x -39.18%
2006-12-31 $861.00 Million $751.00 Million 0.872x -63.47%
2005-12-31 $299.00 Million $714.00 Million 2.388x +1638.91%
2004-12-31 $406.00 Million $-63.00 Million -0.155x -200.61%
2003-12-31 $2.60 Billion $401.00 Million 0.154x -10.95%
2002-12-31 $2.10 Billion $363.00 Million 0.173x -26.75%
2001-12-31 $1.95 Billion $462.00 Million 0.236x --

About Celanese Corporation

NYSE:CE USA Chemicals
Market Cap
$5.61 Billion
Market Cap Rank
#3324 Global
#1152 in USA
Share Price
$51.16
Change (1 day)
-0.14%
52-Week Range
$35.53 - $69.24
All Time High
$169.28
About

Celanese Corporation produces and sells engineered polymers worldwide. It operates through Engineered Materials and Acetyl Chain segments. The company offers ethylene acrylic elastomers, ethylene vinyl acetate pharmaceutical grade copolymers, liquid crystal polymers, long-fiber reinforced thermoplastics, nylon and polypropylene compounds and formulations, polyoxymethylene, ultra-high molecular we… Read more